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Background
Our previous studies identified dicyanocobinamide as a
novel sGC regulator that targets the catalytic region and
synergistically enhances activation of sGC by NO-indepen-
dent regulators. As proof-of-concept study, we designed
and synthesized a set of bifunctional sGC regulators,
which consist of cobinamide analog conjugated to a proto-
porphyrin IX derivative through linkers of varying length
and composition (Figure 1).
Results
The length and composition of the linker was proved to be
crucial for sGC activation. Our results indicate that only
hybrid molecules containing a 13-16 atom chain linker
benefited from synergistic engagement of both heme-bind-
ing region and catalytic domain. The hybrid compounds
containing linkers connected through an ester bond were
not only more stable, but also were more effective than
those connected though an amide. Hybrids with shorter or
longer linkers, or with different linker composition, were
much less potent and were no more active than the
cobyrinic acid component alone. The most effective com-
pound was conjugated through an ester bond, contained a
13 atom chain linker and a triazole group close to the
cobyrinate moiety. This compound displayed more than
60 fold activation of purified sGC.
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Figure 1 Cobinamides analog conjugated to a protoporphyrin IX derivative.
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Conclusion
These studies reinforce the concept that cobinamides
can be used as co-stimulators of sGC activity and pro-
pose the principle for multiple ligand sGC regulators.
Structural insights obtained from these studies lay the
foundation for the creation of future bifunctional sGC
regulators containing cobinamide derivatives. The library
of generated cobyrinic acid building blocks adapted for
“click chemistry” can be used for generation of more
potent hybrids, e.g. hybrids with other heme-targeting
sGC regulators.
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